« Home | Dangerous Drugs Lawsuits - Streets of slaughter » | Dangerous Drugs Lawsuits - ADD Drug Loses FDA Approval » | Dangerous Drugs Lawsuits - Defects more likely from IVF » | Dangerous Drugs Lawsuits - Ebixa, Extended Approval for Treatment of Moderate Alzheimer's Disease » | Dangerous Drugs Lawsuits - Proposition H Dangerous for San Francisco » | Dangerous Drugs Lawsuits - The Epilepsy Foundation issues Call to Action » | Dangerous Drugs Lawsuits - HOME PAGE » | Dangerous Drugs Lawsuits - Cracks in GOP unity becoming more obvious » | Dangerous Drugs Lawsuits - Pain relievers cut the odds of oral cancer by half » | Dangerous Drugs Lawsuits - GeoPharma Announces Dismissal of Class Action Litigation Relating » 

Friday, November 25, 2005

Dangerous Drugs Lawsuits - Astra starts key study for new lung cancer drug


Astra starts key study for new lung cancer drug
Reuters Health - LONDON (Reuters) - AstraZeneca Plc has started recruiting patients for a pivotal phase II/III clinical study of its experimental lung cancer drug AZD2171, Europe's third-biggest drug maker said on Wednesday. trials of a dual-action pill called Zactima, also in

New Impotence Drug Under Review
Grand Junction Daily Sentinel - New Impotence Drug Under Review FRIDAY, Nov. 18 (HealthDay News) -- There's a new, potentially faster-acting competitor on the horizon for Viagra (and Levitra and Cialis) in the battle against impotence. PDE5 than other drugs in its class. Avanafil's great advantage for Because of that fast action, 'the duration of side effects presumably

Carvedilol May Improve Heart Failure and Help Prevent Sudden Death
Medical News Today - shows that Carvedilol, a cardiovascular drug, could be useful in reducing significant anti-arrhythmic action. Compared to other drugs in the same class, researchers say Carvedilol

E-mail this post



Remember me (?)



All personal information that you provide here will be governed by the Privacy Policy of Blogger.com. More...